| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
2002-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-200301127-A1 |
| titleOfInvention |
METHODS OF TREATMENT OF MEDIATED PRIZES OF DISEASES IN MAMMALS PROVIDING INTRODUCTION OF THE DEVELOPING AGENT, SUCH AS GUANIDIN, URINE OR KALIUM IODIDE |
| abstract |
This invention relates to the treatment of prion-associated diseases, such as infectious spongy encephalopathy (TSE), in mammals by administering uncoupling agents or inducing a hyperthermic condition in affected mammals. |
| priorityDate |
2001-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |